ASTARTZ Trademark

Trademark Overview


On Friday, February 25, 2022, a trademark application was filed for ASTARTZ with the United States Patent and Trademark Office. The USPTO has given the ASTARTZ trademark a serial number of 79342589. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by NIHON MEDI-PHYSICS CO., LTD.. The ASTARTZ trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies;...

Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of c...

Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents

Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights

Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive ...
astartz

General Information


Serial Number79342589
Word MarkASTARTZ
Filing DateFriday, February 25, 2022
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7141339
Registration DateTuesday, August 22, 2023
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
Description of MarkThe mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format.
Certificate of Correction for RegistrationIn the statement, line 56 and 57, " The mark consists of the Greek letter alpha plus the term "STARTZ" appearing as "aSTARTZ" and pronounced as "alphaSTARTZ," in stylized format." should be deleted, and "The mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format." should be inserted.
Goods and ServicesPharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
Goods and ServicesIndustrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
Goods and ServicesGranting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
Goods and ServicesResearch and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNIHON MEDI-PHYSICS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 136-0075
JP

Party NameNIHON MEDI-PHYSICS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 136-0075
JP

Party NameNIHON MEDI-PHYSICS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 136-0075
JP

Trademark Events


Event DateEvent Description
Thursday, June 16, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, June 22, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2022APPLICATION FILING RECEIPT MAILED
Friday, September 30, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 9, 2022ASSIGNED TO EXAMINER
Monday, December 19, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 20, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 15, 2023REFUSAL PROCESSED BY MPU
Wednesday, February 15, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 6, 2023REFUSAL PROCESSED BY IB
Monday, April 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 22, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, April 25, 2023WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Wednesday, April 26, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, May 1, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, May 1, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 1, 2023EXAMINER'S AMENDMENT ENTERED
Monday, May 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 15, 2023ASSIGNED TO PETITION STAFF
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 17, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, June 6, 2023NOTIFICATION PROCESSED BY IB
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, August 28, 2023TEAS SECTION 7 REQUEST RECEIVED
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 27, 2023FINAL DISPOSITION PROCESSED
Monday, November 27, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 19, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 10, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, June 18, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED